Men and women aged > 18 years
Angiographically confirmed acute massive pulmonary embolism with involvement of Central pulmonary arteries.
endovascular mechanical thrombus fragmentation + thrombolytic therapy (using recombinant tissue activator of plasminogen), performed for treatment of the above-mentioned pulmonary embolism in less than 48 hours before randomization. The patient should be randomized no earlier than 24 hours after procedures endovascular mechanical thrombus fragmentation + thrombolytic therapy
Written informed consent signed by patient.
